Comment le bénéfice par action récent de IGNE se compare-t-il aux attentes ?
Comment les revenus de Igene Biotechnology Inc IGNE se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Igene Biotechnology Inc ?
Quel est le score de qualité des bénéfices pour Igene Biotechnology Inc ?
Quand Igene Biotechnology Inc publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Igene Biotechnology Inc ?
Igene Biotechnology Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$0
Prix d'ouverture
$0
Plage de la journée
$0 - $0
Plage de 52 semaines
$0 - $0
Volume
50.5K
Volume moyen
0
BPA (TTM)
-0.00
Rendement en dividend
--
Capitalisation boursière
$15.6K
Qu’est-ce que IGNE ?
IGENE Biotechnology, Inc. engages in the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company is headquartered in Columbia, Maryland and currently employs 18 full-time employees. The firm develops, produces and markets specialty biochemical products. The company is a supplier of natural astaxanthin, a nutrient in different feed applications and a source of pigment for coloring farmed salmon species. Igene provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors. The company also provides analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. Within animal nutrition, the Company focus is to deliver astaxanthin to the fish feed market.